Can B Corp.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Can B Corp specializes in the creation, development, and production of next-generation health and wellness products and services, with offerings available through doctor offices, retailers, and online channels. Its product portfolio spans consumer CBD lines under brands such as CanB-MD, Music City Botanicals, Lab2Lounge, Transcendence, Seven Charcras, and B2B offerings from Botanical Biotech, alongside medical devices produced under Duramed and Pure Health Products. The company also manages supply chain operations through Green Grow Farms. Can B Corp provides comprehensive consumer go-to-market strategies that include branding, product development, design, research, testing, and production. Founded and headquartered in Hicksville, New York, Can B Corp emphasizes sustainability by sourcing natural products from its farms and aims to improve health outcomes through science-backed products. Recent strategic moves include expanding its international presence with product rollouts in Brazil through a partnership with Biocase Brasil, enhancing its manufacturing and processing standards to meet high-quality benchmarks. The company continues to focus on growth by targeting higher-end spa, salon, and retail markets with innovative CBD product introductions and fosters strong brand alignment through experienced design and creative teams. The leadership team comprises CEO Marco Alfonsi and CFO Stanley L. Teeple, both serving since 2016 with extensive industry experience. This comprehensive approach positions Can B Corp as a diversified health and wellness company with a robust product range and strategic market expansions.
Can B Corp. Announces Holding Company Reorganization With Nascent Pharma Holdings, Inc. to Become the Publicly-Traded Parent Company
Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million
Can B Corp. Expects Nearly $500,000 Annual Savings With Successful Completion of Move of Pure Health Products From Lacey, WA to Colorado
Can B Corp. Secures 1.8 Million Pounds of Biomass for Awarded Contract With One Bad Moon Rising
Can B Corp. Secures Lease for 300,000 Square Foot Facility in McMinnville, Tennessee
Can B Corp. Strengthens Its Vertical Processing Capabilities With Acquisition of Assets From Music City Botanicals
Can B Corp. Closes Acquisition of Assets from Music City Botanicals to Strengthen its Vertical Processing Capabilities
Can B Corp. Reports 96% Revenue Growth for Its Second Quarter 2021
Can B Corp. Closes Acquisition of Assets from TWS Pharma in CO to Significantly Expand Capabilities in Converting Hemp Biomass to Isolate Used in our CBD and Isomer Product Lines
Can B Corp Announces First Quarter 2021 Results
Can B Corp. Enters the Industrial Hemp Business
Can B Corp. Announces Full Year 2020 Results
Can B Corp. to Present at Virtual Investor Summit on March 23, 2021 at 3:00 PM ET
Can B Corp. Acquires Assets from Leading-Edge Hemp Technology Group
Can B Corp Partners with Signature PR to Launch a New Premier Line
Can B Corp. Accelerates its Innovations and Advancements at Pure Health Products
Can B Corp and Dr. Karl Zarse Launch ImmuneX2